Close Menu

NEW YORK ─ Passage Bio and Invitae on Monday announced that they are collaborating to facilitate genetic testing and support early identification of GM1 gangliosidosis (GM1) through Invitae's Detect Lysosomal Storage Disorders (Detect LSDs) program.

The companies are also partnering to provide clinical trial information to clinicians and patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.